Chih Hui Lin
Chief Executive Officer bei SYNMOSA BIOPHARMA CORPORATION
Aktive Positionen von Chih Hui Lin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SYNMOSA BIOPHARMA CORPORATION | Chief Executive Officer | 25.02.2011 | - |
Chairman | 25.02.2011 | - | |
President | 25.08.1970 | - | |
INNOPHARMAX INC. | Chairman | 21.03.2008 | - |
INTECH BIOPHARM CORPORATION | Chairman | 28.10.2010 | - |
Chief Executive Officer | 28.10.2010 | 11.07.2017 | |
Yu Chiao Co. Ltd. | Chairman | - | - |
U-Liang Pharmaceutical Co. Ltd.
U-Liang Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Synmosa Biopharma Corp., U-Liang Pharmaceutical Co. Ltd. is a Taiwanese company that manufactures and distributes pharmaceutical products. The private company is based in Taoyuan, Taiwan. U-Liang Pharmaceutical Co. was acquired by Synmosa Biopharma Corp. on March 07, 2013 for $2.50 million. | Chairman | - | - |
Karriereverlauf von Chih Hui Lin
Ausbildung von Chih Hui Lin
Taipei Medical University | Undergraduate Degree |
Statistik
International
Taiwan | 7 |
Operativ
Chairman | 5 |
Chief Executive Officer | 2 |
President | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
SYNMOSA BIOPHARMA CORPORATION | Health Technology |
INNOPHARMAX INC. | Health Technology |
INTECH BIOPHARM CORPORATION | Health Technology |
Private Unternehmen | 2 |
---|---|
Yu Chiao Co. Ltd. | |
U-Liang Pharmaceutical Co. Ltd.
U-Liang Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Synmosa Biopharma Corp., U-Liang Pharmaceutical Co. Ltd. is a Taiwanese company that manufactures and distributes pharmaceutical products. The private company is based in Taoyuan, Taiwan. U-Liang Pharmaceutical Co. was acquired by Synmosa Biopharma Corp. on March 07, 2013 for $2.50 million. | Health Technology |
- Börse
- Insiders
- Chih Hui Lin
- Erfahrung